Clinical Trial Update: Study of 2LPAPI® on the Clearance of Genital HR-HPV Infections. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating 2LPAPI® for the clearance of genital high-risk human papillomavirus infections; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Human Papillomavirus Infection

Drugs mentioned

• 2LPAPI®

Snippet

Sponsor: Labo'Life | Conditions: Human Papilloma Virus | Phase 4 | Status: RECRUITING